1
|
Macroalgal Proteins: A Review. Foods 2022; 11:foods11040571. [PMID: 35206049 PMCID: PMC8871301 DOI: 10.3390/foods11040571] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/24/2021] [Revised: 01/31/2022] [Accepted: 02/08/2022] [Indexed: 12/11/2022] Open
Abstract
Population growth is the driving change in the search for new, alternative sources of protein. Macroalgae (otherwise known as seaweeds) do not compete with other food sources for space and resources as they can be sustainably cultivated without the need for arable land. Macroalgae are significantly rich in protein and amino acid content compared to other plant-derived proteins. Herein, physical and chemical protein extraction methods as well as novel techniques including enzyme hydrolysis, microwave-assisted extraction and ultrasound sonication are discussed as strategies for protein extraction with this resource. The generation of high-value, economically important ingredients such as bioactive peptides is explored as well as the application of macroalgal proteins in human foods and animal feed. These bioactive peptides that have been shown to inhibit enzymes such as renin, angiotensin-I-converting enzyme (ACE-1), cyclooxygenases (COX), α-amylase and α-glucosidase associated with hypertensive, diabetic, and inflammation-related activities are explored. This paper discusses the significant uses of seaweeds, which range from utilising their anthelmintic and anti-methane properties in feed additives, to food techno-functional ingredients in the formulation of human foods such as ice creams, to utilising their health beneficial ingredients to reduce high blood pressure and prevent inflammation. This information was collated following a review of 206 publications on the use of seaweeds as foods and feeds and processing methods to extract seaweed proteins.
Collapse
|
2
|
Huang F, Wang K, Shen J. Lipoprotein-associated phospholipase A2: The story continues. Med Res Rev 2019; 40:79-134. [PMID: 31140638 PMCID: PMC6973114 DOI: 10.1002/med.21597] [Citation(s) in RCA: 82] [Impact Index Per Article: 16.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2018] [Revised: 04/20/2019] [Accepted: 04/30/2019] [Indexed: 12/15/2022]
Abstract
Inflammation is thought to play an important role in the pathogenesis of vascular diseases. Lipoprotein-associated phospholipase A2 (Lp-PLA2) mediates vascular inflammation through the regulation of lipid metabolism in blood, thus, it has been extensively investigated to identify its role in vascular inflammation-related diseases, mainly atherosclerosis. Although darapladib, the most advanced Lp-PLA2 inhibitor, failed to meet the primary endpoints of two large phase III trials in atherosclerosis patients cotreated with standard medical care, the research on Lp-PLA2 has not been terminated. Novel pathogenic, epidemiologic, genetic, and crystallographic studies regarding Lp-PLA2 have been reported recently, while novel inhibitors were identified through a fragment-based lead discovery strategy. More strikingly, recent clinical and preclinical studies revealed that Lp-PLA2 inhibition showed promising therapeutic effects in diabetic macular edema and Alzheimer's disease. In this review, we not only summarized the knowledge of Lp-PLA2 established in the past decades but also emphasized new findings in recent years. We hope this review could be valuable for helping researchers acquire a much deeper insight into the nature of Lp-PLA2, identify more potent and selective Lp-PLA2 inhibitors, and discover the potential indications of Lp-PLA2 inhibitors.
Collapse
Affiliation(s)
- Fubao Huang
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, Shanghai, China.,School of Pharmacy, University of Chinese Academy of Sciences, Beijing, China
| | - Kai Wang
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, Shanghai, China
| | - Jianhua Shen
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica (SIMM), Chinese Academy of Sciences, Shanghai, China
| |
Collapse
|
3
|
Morton JS, Care AS, Kirschenman R, Cooke CL, Davidge ST. Advanced Maternal Age Worsens Postpartum Vascular Function. Front Physiol 2017; 8:465. [PMID: 28713290 PMCID: PMC5491844 DOI: 10.3389/fphys.2017.00465] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/11/2017] [Accepted: 06/19/2017] [Indexed: 11/13/2022] Open
Abstract
The age at which women experience their first pregnancy has increased throughout the decades. Pregnancy has an important influence on maternal short- and long-term cardiovascular outcomes. Pregnancy at an advanced maternal age increases maternal risk of gestational diabetes, preeclampsia, placenta previa and caesarian delivery; complications which predict worsened cardiovascular health in later years. Aging also independently increases the risk of cardiovascular disease; therefore, combined risk in women of advanced maternal age may lead to detrimental cardiovascular outcomes later in life. We hypothesized that pregnancy at an advanced maternal age would lead to postpartum vascular dysfunction. We used a reproductively aged rat model to investigate vascular function in never pregnant (virgin), previously pregnant (postpartum) and previously mated but never delivered (nulliparous) rats at approximately 13.5 months of age (3 months postpartum or equivalent). Nulliparous rats, in which pregnancy was spontaneously lost, demonstrated significantly reduced aortic relaxation responses (methylcholine [MCh] Emax: 54.2 ± 12.6%) vs. virgin and postpartum rats (MCh Emax: 84.8 ± 3.5% and 84.7 ± 3.2% respectively); suggesting pregnancy loss causes a worsened vascular pathology. Oxidized LDL reduced relaxation to MCh in aorta from virgin and postpartum, but not nulliparous rats, with an increased contribution of the LOX-1 receptor in the postpartum group. Further, in mesenteric arteries from postpartum rats, endothelium-derived hyperpolarization (EDH)-mediated vasodilation was reduced and a constrictive prostaglandin effect was apparent. In conclusion, aged postpartum rats exhibited vascular dysfunction, while rats which had pregnancy loss demonstrated a distinct vascular pathology. These data demonstrate mechanisms which may lead to worsened outcomes at an advanced maternal age; including early pregnancy loss and later life cardiovascular dysfunction.
Collapse
Affiliation(s)
- Jude S. Morton
- Department of Obstetrics and Gynaecology, University of AlbertaEdmonton, AB, Canada
- Women and Children's Health Research InstituteEdmonton, AB, Canada
| | - Alison S. Care
- Department of Obstetrics and Gynaecology, University of AlbertaEdmonton, AB, Canada
- Women and Children's Health Research InstituteEdmonton, AB, Canada
| | - Raven Kirschenman
- Department of Obstetrics and Gynaecology, University of AlbertaEdmonton, AB, Canada
- Women and Children's Health Research InstituteEdmonton, AB, Canada
| | - Christy-Lynn Cooke
- Department of Obstetrics and Gynaecology, University of AlbertaEdmonton, AB, Canada
- Women and Children's Health Research InstituteEdmonton, AB, Canada
| | - Sandra T. Davidge
- Department of Obstetrics and Gynaecology, University of AlbertaEdmonton, AB, Canada
- Women and Children's Health Research InstituteEdmonton, AB, Canada
- Department of Physiology, University of AlbertaEdmonton, AB, Canada
| |
Collapse
|
4
|
Plasma PAF-AH (PLA2G7): Biochemical Properties, Association with LDLs and HDLs, and Regulation of Expression. Enzymes 2015; 38:71-93. [PMID: 26612648 DOI: 10.1016/bs.enz.2015.09.004] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
This chapter is focused on the plasma form of PAF-acetylhydrolase (PAF-AH), a lipoprotein-bound, calcium-independent phospholipase A2 activity also referred to as lipoprotein-associated phospholipase A2 and PLA2G7. PAF-AH catalyzes the removal of the acyl group at the sn-2 position of PAF and truncated phospholipids generated in settings of inflammation and oxidant stress. Here, I discuss current knowledge related to the structural features of this enzyme, including the molecular basis for association with lipoproteins and susceptibility to oxidative inactivation. The circulating form of PAF-AH is constitutively active and its expression is upregulated by mediators of inflammation at the transcriptional level. Several new mechanisms of regulation have been identified in recent years, including effects mediated by PPARs, VEGFR, and the state of cellular differentiation. Moreover, I discuss recent studies describing significant variations in the structure and regulation of PAF-AH from diverse species, which is likely to have important implications for the function of this enzyme in vivo.
Collapse
|
5
|
Flasiński M, Broniatowski M, Wydro P, Hąc-Wydro K, Dynarowicz-Łątka P. Behavior of platelet activating factor in membrane-mimicking environment. Langmuir monolayer study complemented with grazing incidence X-ray diffraction and Brewster angle microscopy. J Phys Chem B 2012; 116:10842-55. [PMID: 22834697 DOI: 10.1021/jp302907e] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
1-O-octadecyl-2-acetyl-sn-glycero-3-phosphocholine (PAF) belonging to the class of single-chained ether phospholipids is widely known from its essential biological activities. There is a growing body of evidence that some significant aspects of PAF actions are connected with its capability to direct intercalation into biomembranes' environment. Although this mechanism is of great importance in the perspective of understanding PAF implications in various physiological processes, in the literature, there is a lack of studies devoted to this subject. It is still unknown which is the exact influence of membrane composition, molecular organization, and its other properties on the PAF impact on cells and tissues. Unfortunately, the biological studies carried out on cell cultures do not provide satisfactory results, mainly because of the complexity of natural systems. In order to obtain insight into the behavior of PAF in a lipid environment at the molecular level, the application of appropriate model systems is required. Among them, Langmuir monolayers are very often applied as a simple but very efficient platform for studies of the interactions between membrane lipids. In the present paper, special attention is focused on the issue concerning the interactions between PAF and two representatives of membrane components occurring mainly in the outer leaflet of natural bilayers, namely, cholesterol and DPPC. The application of Langmuir monolayers enabled us to construct the effective model mimicking the exogenous incorporation of PAF into membrane environment. On the basis of the obtained results, a thorough discussion was carried out and the conclusions derived from the traditional thermodynamic analysis were confronted with microscopic analysis of surface domains and the GIXD results. The selection of experimental techniques enables us to obtain information regarding the miscibility and interactions in the binary mixed films as well as the molecular organization of film-forming molecules on water surface. The experiments revealed that the addition of the investigated single-chained ether phospholipid into both cholesterol and DPPC monolayers causes a considerable decrease of monolayer condensation. On the basis of thermodynamic analysis, it was found that PAF mixes and consequently interacts strongly with cholesterol, whereas its interactions with DPPC are thermodynamically unfavorable. Differences between the PAF influence on cholesterol and DPPC monolayer found its corroboration in the results obtained with the GIXD technique. Namely, the monolayer of DPPC can incorporate more PAF than the model membrane containing cholesterol. The obtained results indicate that short chained sn-2 ether phospholipid is able to modify model membrane properties in a concentration-dependent way.
Collapse
Affiliation(s)
- Michał Flasiński
- Faculty of Chemistry, Jagiellonian University, Ingardena 3, 30-060 Kraków, Poland.
| | | | | | | | | |
Collapse
|
6
|
Flasiński M, Broniatowski M, Wydro P, Dynarowicz-Łątka P. Comparative Characteristics of Membrane-Active Single-Chained Ether Phospholipids: PAF and Lyso-PAF in Langmuir Monolayers. J Phys Chem B 2012; 116:3155-63. [DOI: 10.1021/jp2121092] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Affiliation(s)
- Michał Flasiński
- Faculty of Chemistry, Jagiellonian University, Ingardena 3, 30-060 Kraków, Poland
| | - Marcin Broniatowski
- Faculty of Chemistry, Jagiellonian University, Ingardena 3, 30-060 Kraków, Poland
| | - Paweł Wydro
- Faculty of Chemistry, Jagiellonian University, Ingardena 3, 30-060 Kraków, Poland
| | | |
Collapse
|
7
|
Xiao Q, Pepe AE, Wang G, Luo Z, Zhang L, Zeng L, Zhang Z, Hu Y, Ye S, Xu Q. Nrf3-Pla2g7 interaction plays an essential role in smooth muscle differentiation from stem cells. Arterioscler Thromb Vasc Biol 2012; 32:730-44. [PMID: 22247257 DOI: 10.1161/atvbaha.111.243188] [Citation(s) in RCA: 43] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
OBJECTIVE Phospholipase A2, group 7 (Pla2g7) is an important mediator in cardiovascular development and diseases because of its divergent physiological and pathological functions in inflammation and oxidative stress. However, little is known about the functional role of Pla2g7 in smooth muscle cell (SMC) differentiation from stem cells. METHODS AND RESULTS In the present study, embryonic stem cells were cultivated on collagen IV-coated plates to allow SMC differentiation. Pla2g7 gene expression and activity were upregulated significantly following 4 to 14 days of cell differentiation and colocalized with SMC differentiation markers in the differentiated SMCs. Knockdown of Pla2g7 resulted in downregulation of smooth muscle-specific markers in vitro and impairment of SMC differentiation in vivo, whereas enforced expression of Pla2g7 enhanced SMC differentiation and increased reactive oxygen species generation. Importantly, enforced expression of Pla2g7 significantly increased the binding of serum response factor to SMC differentiation gene promoters, resulting in SMC differentiation, which was abolished by free radical scavenger and flavoprotein inhibitor of NADPH oxidase but not hydrogen peroxide inhibitor. Moreover, we demonstrated that nuclear factor erythroid 2-related factor 3 (Nrf3) regulates Pla2g7 gene expression through direct binding to the promoter regions of Pla2g7 gene. CONCLUSION Our findings demonstrated that Pla2g7 plays a crucial physiological role in SMC differentiation from stem cells, and the fine interactions between Nrf3 and Pla2g7 are essential for SMC differentiation.
Collapse
Affiliation(s)
- Qingzhong Xiao
- Centre for Clinical Pharmacology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, Charterhouse Square, London EC1M 6BQ, United Kingdom.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
8
|
Dennis EA, Cao J, Hsu YH, Magrioti V, Kokotos G. Phospholipase A2 enzymes: physical structure, biological function, disease implication, chemical inhibition, and therapeutic intervention. Chem Rev 2011; 111:6130-85. [PMID: 21910409 PMCID: PMC3196595 DOI: 10.1021/cr200085w] [Citation(s) in RCA: 804] [Impact Index Per Article: 61.8] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Affiliation(s)
- Edward A. Dennis
- Department of Chemistry and Biochemistry and Pharmacology, School of Medicine, University of California, San Diego, La Jolla, California 92093-0601
| | - Jian Cao
- Department of Chemistry and Biochemistry and Pharmacology, School of Medicine, University of California, San Diego, La Jolla, California 92093-0601
| | - Yuan-Hao Hsu
- Department of Chemistry and Biochemistry and Pharmacology, School of Medicine, University of California, San Diego, La Jolla, California 92093-0601
| | - Victoria Magrioti
- Laboratory of Organic Chemistry, Department of Chemistry, University of Athens, Panepistimiopolis, Athens 15771, Greece
| | - George Kokotos
- Laboratory of Organic Chemistry, Department of Chemistry, University of Athens, Panepistimiopolis, Athens 15771, Greece
| |
Collapse
|
9
|
Suckling K. Phospholipase A2s: Developing drug targets for atherosclerosis. Atherosclerosis 2010; 212:357-66. [DOI: 10.1016/j.atherosclerosis.2010.03.011] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/23/2009] [Revised: 03/08/2010] [Accepted: 03/08/2010] [Indexed: 12/24/2022]
|
10
|
De Keyzer D, Karabina SA, Wei W, Geeraert B, Stengel D, Marsillach J, Camps J, Holvoet P, Ninio E. Increased PAFAH and Oxidized Lipids Are Associated With Inflammation and Atherosclerosis in Hypercholesterolemic Pigs. Arterioscler Thromb Vasc Biol 2009; 29:2041-6. [DOI: 10.1161/atvbaha.109.196592] [Citation(s) in RCA: 50] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
Objective—
To study the association of PAF-acetyl hydrolase (PAFAH) activity with inflammation, oxidative stress, and atherosclerosis in hypercholesterolemic swine.
Methods and Results—
Cholesterol-rich diet feeding of miniature pigs was associated with an increase in PAFAH activity and an increase of the PAFAH to PON1 ratio.
PLA2G7
RNA (coding for PAFAH) expression was increased in blood monocytes and plaque macrophages. Increased PAFAH activity was associated with higher plasma lysophosphatidylcholine and correlated with oxidized LDL. In THP1 monocytes and macrophages and in human blood-derived macrophages, oxidized LDL induced
PLA2G7
RNA expression. Atherogenic diet feeding induced the accumulation of macrophages and oxidized LDL in the arterial wall leading to atherosclerosis. PAFAH activity correlated positively with plaque size and
TNFalpha
expression in plaque macrophages.
Conclusions—
We demonstrated that an increase in PAFAH activity was associated with increased levels of lysophosphatidylcholine, oxidized LDL, and inflammation, resulting in accelerated atherosclerosis in hypercholesterolemic minipigs. The significant correlation between
PLA2G7
RNA expression in plaque macrophages and plasma PAFAH activity suggests that the latter is a consequence, rather than a cause of macrophage accumulation. Our cell experiments suggest that oxidized LDL can induce PAFAH, resulting in accumulation of lysophosphatidylcholine that increases the inflammatory action of oxidized LDL.
Collapse
Affiliation(s)
- Dieuwke De Keyzer
- From the Atherosclerosis and Metabolism Unit, Department of Cardiovascular Diseases (D.DK., B.G., P.H.), Katholieke Universiteit Leuven, Belgium; INSERM UMRS937 (S.A.K., W.W., D.S., E.N.), Université Pierre et Marie Curie UPMC-Paris 6 and Faculté de Médecine Pierre et Marie Curie, Paris, France; and Centre de Recerca Biomèdica (J.M., J.C.), Hospital Universitari de Sant Joan, Catalunya, Spain. Current affiliation for W.W.: Department of Biochemistry, University of Nebraska, Lincoln
| | - Sonia-Athina Karabina
- From the Atherosclerosis and Metabolism Unit, Department of Cardiovascular Diseases (D.DK., B.G., P.H.), Katholieke Universiteit Leuven, Belgium; INSERM UMRS937 (S.A.K., W.W., D.S., E.N.), Université Pierre et Marie Curie UPMC-Paris 6 and Faculté de Médecine Pierre et Marie Curie, Paris, France; and Centre de Recerca Biomèdica (J.M., J.C.), Hospital Universitari de Sant Joan, Catalunya, Spain. Current affiliation for W.W.: Department of Biochemistry, University of Nebraska, Lincoln
| | - Wenhzong Wei
- From the Atherosclerosis and Metabolism Unit, Department of Cardiovascular Diseases (D.DK., B.G., P.H.), Katholieke Universiteit Leuven, Belgium; INSERM UMRS937 (S.A.K., W.W., D.S., E.N.), Université Pierre et Marie Curie UPMC-Paris 6 and Faculté de Médecine Pierre et Marie Curie, Paris, France; and Centre de Recerca Biomèdica (J.M., J.C.), Hospital Universitari de Sant Joan, Catalunya, Spain. Current affiliation for W.W.: Department of Biochemistry, University of Nebraska, Lincoln
| | - Benjamine Geeraert
- From the Atherosclerosis and Metabolism Unit, Department of Cardiovascular Diseases (D.DK., B.G., P.H.), Katholieke Universiteit Leuven, Belgium; INSERM UMRS937 (S.A.K., W.W., D.S., E.N.), Université Pierre et Marie Curie UPMC-Paris 6 and Faculté de Médecine Pierre et Marie Curie, Paris, France; and Centre de Recerca Biomèdica (J.M., J.C.), Hospital Universitari de Sant Joan, Catalunya, Spain. Current affiliation for W.W.: Department of Biochemistry, University of Nebraska, Lincoln
| | - Dominique Stengel
- From the Atherosclerosis and Metabolism Unit, Department of Cardiovascular Diseases (D.DK., B.G., P.H.), Katholieke Universiteit Leuven, Belgium; INSERM UMRS937 (S.A.K., W.W., D.S., E.N.), Université Pierre et Marie Curie UPMC-Paris 6 and Faculté de Médecine Pierre et Marie Curie, Paris, France; and Centre de Recerca Biomèdica (J.M., J.C.), Hospital Universitari de Sant Joan, Catalunya, Spain. Current affiliation for W.W.: Department of Biochemistry, University of Nebraska, Lincoln
| | - Judit Marsillach
- From the Atherosclerosis and Metabolism Unit, Department of Cardiovascular Diseases (D.DK., B.G., P.H.), Katholieke Universiteit Leuven, Belgium; INSERM UMRS937 (S.A.K., W.W., D.S., E.N.), Université Pierre et Marie Curie UPMC-Paris 6 and Faculté de Médecine Pierre et Marie Curie, Paris, France; and Centre de Recerca Biomèdica (J.M., J.C.), Hospital Universitari de Sant Joan, Catalunya, Spain. Current affiliation for W.W.: Department of Biochemistry, University of Nebraska, Lincoln
| | - Jordi Camps
- From the Atherosclerosis and Metabolism Unit, Department of Cardiovascular Diseases (D.DK., B.G., P.H.), Katholieke Universiteit Leuven, Belgium; INSERM UMRS937 (S.A.K., W.W., D.S., E.N.), Université Pierre et Marie Curie UPMC-Paris 6 and Faculté de Médecine Pierre et Marie Curie, Paris, France; and Centre de Recerca Biomèdica (J.M., J.C.), Hospital Universitari de Sant Joan, Catalunya, Spain. Current affiliation for W.W.: Department of Biochemistry, University of Nebraska, Lincoln
| | - Paul Holvoet
- From the Atherosclerosis and Metabolism Unit, Department of Cardiovascular Diseases (D.DK., B.G., P.H.), Katholieke Universiteit Leuven, Belgium; INSERM UMRS937 (S.A.K., W.W., D.S., E.N.), Université Pierre et Marie Curie UPMC-Paris 6 and Faculté de Médecine Pierre et Marie Curie, Paris, France; and Centre de Recerca Biomèdica (J.M., J.C.), Hospital Universitari de Sant Joan, Catalunya, Spain. Current affiliation for W.W.: Department of Biochemistry, University of Nebraska, Lincoln
| | - Ewa Ninio
- From the Atherosclerosis and Metabolism Unit, Department of Cardiovascular Diseases (D.DK., B.G., P.H.), Katholieke Universiteit Leuven, Belgium; INSERM UMRS937 (S.A.K., W.W., D.S., E.N.), Université Pierre et Marie Curie UPMC-Paris 6 and Faculté de Médecine Pierre et Marie Curie, Paris, France; and Centre de Recerca Biomèdica (J.M., J.C.), Hospital Universitari de Sant Joan, Catalunya, Spain. Current affiliation for W.W.: Department of Biochemistry, University of Nebraska, Lincoln
| |
Collapse
|
11
|
The role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma. Biochim Biophys Acta Mol Cell Biol Lipids 2009; 1791:327-38. [PMID: 19272461 DOI: 10.1016/j.bbalip.2009.02.015] [Citation(s) in RCA: 117] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2008] [Revised: 02/06/2009] [Accepted: 02/19/2009] [Indexed: 01/28/2023]
Abstract
Platelet-activating factor (PAF) acetylhydrolase exhibits a Ca(2+)-independent phospholipase A2 activity and degrades PAFas well as oxidized phospholipids (oxPL). Such phospholipids are accumulated in the artery wall and may play key roles in vascular inflammation and atherosclerosis. PAF-acetylhydrolase in plasma is complexed to lipoproteins; thus it is also referred to as lipoprotein-associated phospholipase A2 (Lp-PLA2). Lp-PLA2 is primarily associated with low-density lipoprotein (LDL), whereas a small proportion of circulating enzyme activity is also associated with high-density lipoprotein (HDL). The majority of the LDL-associated Lp-PLA2 (LDL-Lp-PLA2) activity is bound to atherogenic small-dense LDL particles and it is a potential marker of these particles in plasma. The distribution of Lp-PLA2 between LDL and HDL is altered in various types of dyslipidemias. It can be also influenced by the presence of lipoprotein (a) [Lp(a)] when plasma levels of this lipoprotein exceed 30 mg/dl. Several lines of evidence suggest that the role of plasma Lp-PLA2 in atherosclerosis may depend on the type of lipoprotein particle with which this enzyme is associated. In this regard, data from large Caucasian population studies have shown an independent association between the plasma Lp-PLA2 levels (which are mainly influenced by the levels of LDL-Lp-PLA2) and the risk of future cardiovascular events. On the contrary, several lines of evidence suggest that HDL-associated Lp-PLA2 may substantially contribute to the HDL antiatherogenic activities. Recent studies have provided evidence that oxPL are preferentially sequestered on Lp(a) thus subjected to degradation by the Lp(a)-associated Lp-PLA2. These data suggest that Lp(a) may be a potential scavenger of oxPL and provide new insights into the functional role of Lp(a) and the Lp(a)-associated Lp-PLA2 in normal physiology as well as in inflammation and atherosclerosis. The present review is focused on recent advances concerning the Lp-PLA2 structural characteristics, the molecular basis of the enzyme association with distinct lipoprotein subspecies, as well as the potential role of Lp-PLA2 associated with different lipoprotein classes in atherosclerosis and cardiovascular disease.
Collapse
|
12
|
Stafforini DM. Biology of platelet-activating factor acetylhydrolase (PAF-AH, lipoprotein associated phospholipase A2). Cardiovasc Drugs Ther 2008; 23:73-83. [PMID: 18949548 DOI: 10.1007/s10557-008-6133-8] [Citation(s) in RCA: 161] [Impact Index Per Article: 10.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/31/2008] [Accepted: 08/06/2008] [Indexed: 12/26/2022]
Abstract
INTRODUCTION This article is focused on platelet-activating factor acetylhydrolase (PAF-AH), a lipoprotein bound, calcium-independent phospholipase A(2) activity also referred to as lipoprotein-associated phospholipase A(2) or PLA(2)G7. PAF-AH catalyzes the removal of the acyl group at the sn-2 position of PAF and truncated phospholipids generated in settings of inflammation and oxidant stress. DISCUSSION Here, I discuss current knowledge related to the structural features of this enzyme, including the molecular basis for association with lipoproteins and susceptibility to oxidative inactivation. The circulating form of PAF-AH is constitutively active and its expression is upregulated by mediators of inflammation at the transcriptional level. This mechanism is likely responsible for the observed up-regulation of PAF-AH during atherosclerosis and suggests that increased expression of this enzyme is a physiological response to inflammatory stimuli. Administration of recombinant forms of PAF-AH attenuate inflammation in a variety of experimental models. Conversely, genetic deficiency of PAF-AH in defined human populations increases the severity of atherosclerosis and other syndromes. Recent advances pointing to an interplay among oxidized phospholipid substrates, Lp(a), and PAF-AH could hold the key to a number of unanswered questions.
Collapse
Affiliation(s)
- Diana M Stafforini
- Huntsman Cancer Institute and Department of Internal Medicine, University of Utah, 2000 Circle of Hope, Suite 3364, Salt Lake City, UT 84112-5550, USA.
| |
Collapse
|